BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 10
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27

• Pharm Country

  Echo Therapeutics Announces Positive CE Mark Regulatory Trial Results Of Symphony® CGM System

  November 26, 2013

   · 

  1 min read
• Drug Development

  Merrimack Pharmaceuticals Inc.'s MM-121 Demonstrates Positive Signal In Two Phase 2 Breast Cancer Studies; Stock Up +11.46% At Market Close (November 26, 2013)

  November 26, 2013

   · 

  8 min read
• BioCapital

  FDA Lifts Constraints On GlaxoSmithKline Diabetes Drug Avandia

  November 26, 2013

   · 

  1 min read
• FDA

  FDA Approves Merck & Co., Inc.'s NOXAFIL® (posaconazole) Delayed-Release Tablets

  November 26, 2013

   · 

  14 min read
• Business

  OraSure Technologies, Inc. Reaffirms 4th Quarter 2013 Financial Guidance

  November 26, 2013

   · 

  1 min read
• Genetown

  Parcell Laboratories Release: New Stem Cell Platform Technology Recognized With Patent Award

  November 26, 2013

   · 

  3 min read
• Business

  Egalet, Shionogi Limited Ink Opiod Pact Worth $425 Million+

  November 26, 2013

   · 

  5 min read
• Business

  Agalimmune Limited Founded To Develop Immunotherapeutics For Cancer

  November 26, 2013

   · 

  5 min read
• Business

  Owner of AstraZeneca PLC Site, Loughborough In “Advanced Talks” With Would-Be Tenant

  November 26, 2013

   · 

  1 min read
• Business

  Cerespir Incorporated Appoints Richard Margolin, MD, As Vice President, Clinical Development

  November 26, 2013

   · 

  1 min read